ورود
مقالات فارسیISIکنفرانسهاژورنالها

Irbesartan ameliorates inflammation via transendothelial leukocyte migration due to VCAM-۱/NOX-۱ signaling in cisplatin-induced cardiotoxicity

محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 26، شماره: 11
سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 48

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:
https://civilica.com/doc/1767647

شناسه ملی سند علمی:

JR_IJBMS-26-11_006

تاریخ نمایه سازی: 4 مهر 1402

چکیده مقاله:

Objective(s): Cisplatin (CP) is frequently used in various types of cancers. The cardiotoxic effects of this agent limit its usage. Our study seeks to investigate the protective effects of Irbesartan (IRB) on CP-induced cardiotoxicity. Materials and Methods: The following four groups comprised thirty-two rats: control, CP, CP+IRB, and IRB. On the fourth day of the experiment, ۵ mg/kg of CP was given to CP and CP+IRB groups intraperitoneally, and for seven days, water or IRB ۵۰ mg/kg (orally) was administered. Vascular endothelial growth factor (VEGF), caspase-۳ (Cas-۳), vascular cell adhesion molecule-۱ (VCAM-۱), NADPH oxidase-۱ (NOX-۱), creatine kinase MB (CK-MB), and lactate dehydrogenase (LDH) were measured. Results: The levels of VCAM-۱, NOX-۱, VEGF, Cas-۳, and LDH were increased in the CP group. The treatment with IRB decreased VCAM-۱, NOX-۱, VEGF, Cas-۳, and LDH levels significantly  (P<۰.۰۵). Histopathological examination revealed normal heart architecture in Control and IRB groups. While marked hyperemia and myocardial cell degeneration were noticed in the CP group, significant amelioration was observed in the CP+IRB group. Aortas in the CP group showed endothelial damage and desquamation. IRB treatment markedly ameliorated histopathological findings in the CP+IRB group. Cardiac and aortic damage caused by CP was attenuated by IRB treatment owing to the anti-inflammatory and antiapoptotic effects of IRB.Conclusion: IRB may help reduce the severity of CP-induced cardiac injury by limiting leukocyte migration and reducing inflammation and apoptosis.

کلیدواژه ها:

Cardiotoxicity ، Cisplatin ، Irbesartan ، VCAM-۱ ، VEGF

نویسندگان

Dilek Ulusoy Karatopuk

Department of Histology and Embryology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey

Songül Özkula

Department of Pharmacology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey

Esra Aydoğdu

Department of Pharmaceutical Research and Development, Health Science Institute, Süleyman Demirel University, Isparta, Turkey

Halil İbrahim Büyükbayram

Department of Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey

Adem Milletsever

Department of Pathology, Faculty of Veterinary Medicine, Mehmet Akif Ersoy University, Burdur, Turkey

Fatih Aksoy

Department of Cardiology and Department of Pharmacology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg ...
  • Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, ...
  • Herrmann J. Cardiovascular toxicity with cisplatin in patients with testicular ...
  • Varga ZV, Ferdinandy P, Liaudet L, Pacher P. Drug-induced mitochondrial ...
  • Chowdhury S, Sinha K, Banerjee S, Sil PC. Taurine protects ...
  • Nuver J, Smit AJ, Wolffenbuttel BH, Sluiter WJ, Hoekstra HJ, ...
  • Nuver J, Smit AJ, Sleijfer DT, van Gessel AI, van ...
  • Sypniewska G. Pro-inflammatory and prothrombotic factors and metabolic syndrome. EJIFCC ...
  • Guerrero-Beltrán CE, Mukhopadhyay P, Horváth B, Rajesh M, Tapia E, ...
  • Kim H-J, Ravichandran K, Ozkok A, Wang Q, He Z, ...
  • Kong D-H, Kim YK, Kim MR, Jang JH, Lee S. ...
  • Zhong L, Simard MJ, Huot J. Endothelial microRNAs regulating the ...
  • Bayrak S, Aktaş S, Altun Z, Çakir Y, Tütüncü M, ...
  • Gunturk E, Yucel B, Gunturk I, Yazici C, Yay A, ...
  • Qian P, Yan LJ, Li YQ, Yang HT, Duan HY, ...
  • Gianni D, Nicolas N, Zhang H, Der Mardirossian C, Kister ...
  • Cano-Domínguez N, Bowman B, Peraza-Reyes L, Aguirre J. Neurospora crassa ...
  • García-Redondo AB, Aguado A, Briones AM, Salaices M. NADPH oxidases ...
  • Kim HJ, Lee JH, Kim SJ, Oh GS, Moon HD, ...
  • Darwish IA, Darwish HW, Bakheit AH, Al-Kahtani HM, Alanazi Z. ...
  • El-Said NT, Mohamed EA, Taha RA. Irbesartan suppresses cardiac toxicity ...
  • Fang LN, Zhong S, Huang LJ, Lu B, Shen LW, ...
  • Alibakhshi T, Khodayar MJ, Khorsandi L, Rashno M, Zeidooni L. ...
  • Shahin NN, Abdelkader NF, Safar MM. A novel role of ...
  • Chen C, Liang Z, Chen Q, Li ZG. Irbesartan and ...
  • van den Belt-Dusebout AW, Nuver J, de Wit R, Gietema ...
  • van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas ...
  • El-Hawwary AA, Omar NM. The influence of ginger administration on ...
  • Zhao L, Xing C, Sun W, Hou G, Yang G, ...
  • Bosl GJ, Leitner S, Atlas S, Sealey J, Preibisz J, ...
  • Kranzhöfer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, ...
  • Han Y, Runge MS, Brasier AR. Angiotensin II induces interleukin-۶ ...
  • Candido R, Allen TJ, Lassila M, Cao Z, Thallas V, ...
  • Brandes RP, Schröder K. Differential vascular functions of Nox family ...
  • Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, ...
  • Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, ...
  • Sadok A, Bourgarel-Rey V, Gattacceca F, Penel C, Lehmann M, ...
  • Matsuno K, Iwata K, Matsumoto M, Katsuyama M, Cui W, ...
  • El-Naga RN. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in ...
  • Jung H-Y, Oh S-H, Ahn J-S, Oh E-J, Kim Y-J, ...
  • Dikalova A, Clempus R, Lassègue B, Cheng G, McCoy J, ...
  • Xu WT, Shen GN, Li TZ, Zhang Y, Zhang T, ...
  • Khalilzadeh B, Shadjou N, Kanberoglu GS, Afsharan H, De La ...
  • Shaik-Dasthagirisaheb Y, Varvara G, Murmura G, Saggini A, Potalivo G, ...
  • Al-Kuraishy HM, Al-Gareeb AI, Al-Naimi MS. Renoprotective effect of irbesartan ...
  • Mohamed EA, Ahmed HI, Zaky HS. Protective effect of irbesartan ...
  • Ma R, Zhao Y, Yu X, Li N, Wang Q, ...
  • Fang L-n, Zhong S, Huang L-j, Lu B, Shen L-w, ...
  • Zhang H, Tao M, Kang PF, Guo JL, Xuan L, ...
  • Villalba N, Baby S, Yuan SY. The endothelial glycocalyx as ...
    • نمایش کامل مراجع